BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

TomTec Imaging Systems GmbH Receives FDA 510(k) Clearance for 4D MV-Assessment(C) 2.0 Software- the Solution for Improved Diagnostic Confidence in Mitral Valve Diagnostic Using 4D Ultrasound


2/15/2011 6:19:23 AM

MUNICH, Germany--(BUSINESS WIRE)-- TomTec Imaging Systems GmbH announces the FDA 510(k) clearance for its new 4D MV-Assessment© 2.0 product. The software uses real-time three-dimensional echocardiography (3DE) for the analysis of the mitral valve. Within less than a minute, 4D MV-Assessment© 2.0 derives static and dynamic measurements of the entire mitral valve apparatus. This solution is tailored to clinical setups where precise diagnosis meets the demand of topmost efficiency.

Automated features and a “smart workflow” have considerably shortened analysis times and supply users with accurate information for their clinical decision in seconds.

Understanding the non-planar, three-dimensional geometry of the mitral valve (MV) has been shown to be an important aspect regarding the treatment of mitral valve disease. Such as better understanding of geometric determinants in cases of functional mitral regurgitation can improve individualized surgical planning and thus lead to better outcomes.

“We developed the 4D MV-Assessment© software considering input from leading clinical partners around the world, with an emphasis on user-friendliness and accuracy. Receiving FDA clearance for 4D MV-Assessment© is a major step for us. We have proven again that TomTec offers solutions which are ’One-Step-Ahead’, says Frank Schlau, TomTec’s Chief Marketing Officer.”

About TomTec: Since 20 years TomTec Imaging Systems GmbH, with headquarters located in Munich, Germany holds an inventive leadership position in the field of diagnostic medical imaging applications and Cardio PACS solutions. The company maintains close working relationships with many leading universities and device manufacturers around the world. TomTec’s product portfolio encompasses a wide range of 2D and 3D/4D technologies for visualization, analysis, reporting and archiving of multimodality imaging data. TomTec solutions are applicable in the fields of Adult- and Pediatric Cardiology as well as Obstetrics, Gynaecology, Radiology, and Vascular Imaging. Visit TomTec's web site at www.tomtec.de.

Contact:

TomTec Imaging Systems GmbH Frank Schlau Tel: +49 (0) 89 32175 500 marketing@tomtec.de


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->